Goldman Jonathan (CIK 2013869) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-31). Recent activity: Buy AVTX (3,166 shares), Sell AVTX (3,167 shares), Buy AVTX (8,200 shares), Sell AVTX (8,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,166 | $0 |
| 2025-11-17 | Avalo Therapeutics, Inc. (AVTX) | Director | Sell | 3,167 | $45,288 |
| 2025-11-17 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 8,200 | $81,016 |
| 2025-11-17 | Avalo Therapeutics, Inc. (AVTX) | Director | Sell | 8,200 | $117,670 |
来源：SEC Form 4 申报文件 · 截至 2026-03-31